Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219399 · ClinicalTrials.gov registry record · NA
DHA Supplementation and Pregnancy Outcome
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 871
- Enrollment target
NCT02219399 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 871 participants.
The verdict
NCT02219399, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 871 participants
- Enrollment target
Study Summary
Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 600 mg DHA
- DIETARY_SUPPLEMENT 300 mg DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 871 participants |
| Start Date | 2001-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02219399
The ClinicalTrials.gov registry entry for NCT02219399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 871 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02219399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02219399 about?
NCT02219399 is a clinical study titled "DHA Supplementation and Pregnancy Outcome". Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
What is the current status of trial NCT02219399?
This trial is currently completed. It is a NA study. The enrollment target is 871 participants. The study started on 2001-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02219399?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 600 mg DHA (DIETARY_SUPPLEMENT), 300 mg DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02219399?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.